332 related articles for article (PubMed ID: 26438152)
1. Functional analyses of ATM, ATR and Fanconi anemia proteins in lung carcinoma : ATM, ATR and FA in lung carcinoma.
Beumer JH; Fu KY; Anyang BN; Siegfried JM; Bakkenist CJ
BMC Cancer; 2015 Oct; 15():649. PubMed ID: 26438152
[TBL] [Abstract][Full Text] [Related]
2. ATR-ATRIP kinase complex triggers activation of the Fanconi anemia DNA repair pathway.
Shigechi T; Tomida J; Sato K; Kobayashi M; Eykelenboom JK; Pessina F; Zhang Y; Uchida E; Ishiai M; Lowndes NF; Yamamoto K; Kurumizaka H; Maehara Y; Takata M
Cancer Res; 2012 Mar; 72(5):1149-56. PubMed ID: 22258451
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of ATR-dependent feedback activation of Chk1 sensitises cancer cells to Chk1 inhibitor monotherapy.
Massey AJ
Cancer Lett; 2016 Dec; 383(1):41-52. PubMed ID: 27693461
[TBL] [Abstract][Full Text] [Related]
4. Resveratrol causes Cdc2-tyr15 phosphorylation via ATM/ATR-Chk1/2-Cdc25C pathway as a central mechanism for S phase arrest in human ovarian carcinoma Ovcar-3 cells.
Tyagi A; Singh RP; Agarwal C; Siriwardana S; Sclafani RA; Agarwal R
Carcinogenesis; 2005 Nov; 26(11):1978-87. PubMed ID: 15975956
[TBL] [Abstract][Full Text] [Related]
5. The orally active and bioavailable ATR kinase inhibitor AZD6738 potentiates the anti-tumor effects of cisplatin to resolve ATM-deficient non-small cell lung cancer in vivo.
Vendetti FP; Lau A; Schamus S; Conrads TP; O'Connor MJ; Bakkenist CJ
Oncotarget; 2015 Dec; 6(42):44289-305. PubMed ID: 26517239
[TBL] [Abstract][Full Text] [Related]
6. Regulation of the Fanconi Anemia DNA Repair Pathway by Phosphorylation and Monoubiquitination.
Ishiai M
Genes (Basel); 2021 Nov; 12(11):. PubMed ID: 34828369
[TBL] [Abstract][Full Text] [Related]
7. Fanconi anemia pathway-deficient tumor cells are hypersensitive to inhibition of ataxia telangiectasia mutated.
Kennedy RD; Chen CC; Stuckert P; Archila EM; De la Vega MA; Moreau LA; Shimamura A; D'Andrea AD
J Clin Invest; 2007 May; 117(5):1440-9. PubMed ID: 17431503
[TBL] [Abstract][Full Text] [Related]
8. Loss of CHK1 function impedes DNA damage-induced FANCD2 monoubiquitination but normalizes the abnormal G2 arrest in Fanconi anemia.
Guervilly JH; Macé-Aimé G; Rosselli F
Hum Mol Genet; 2008 Mar; 17(5):679-89. PubMed ID: 18029388
[TBL] [Abstract][Full Text] [Related]
9. The enrichment of Fanconi anemia/homologous recombination pathway aberrations in ATM/ATR-mutated NSCLC was accompanied by unique molecular features and poor prognosis.
Wei W; Shi F; Xu Y; Jiao Y; Zhang Y; Ou Q; Wu X; Yang L; Lai J
J Transl Med; 2023 Dec; 21(1):874. PubMed ID: 38041093
[TBL] [Abstract][Full Text] [Related]
10. The ATM-Chk2 and ATR-Chk1 pathways in DNA damage signaling and cancer.
Smith J; Tho LM; Xu N; Gillespie DA
Adv Cancer Res; 2010; 108():73-112. PubMed ID: 21034966
[TBL] [Abstract][Full Text] [Related]
11. Suppression of the FA pathway combined with CHK1 inhibitor hypersensitize lung cancer cells to gemcitabine.
Dai CH; Wang Y; Chen P; Jiang Q; Lan T; Li MY; Su JY; Wu Y; Li J
Sci Rep; 2017 Nov; 7(1):15031. PubMed ID: 29118324
[TBL] [Abstract][Full Text] [Related]
12. The DNA crosslink-induced S-phase checkpoint depends on ATR-CHK1 and ATR-NBS1-FANCD2 pathways.
Pichierri P; Rosselli F
EMBO J; 2004 Mar; 23(5):1178-87. PubMed ID: 14988723
[TBL] [Abstract][Full Text] [Related]
13. Pharmacologic inhibition of ATR and ATM offers clinically important distinctions to enhancing platinum or radiation response in ovarian, endometrial, and cervical cancer cells.
Teng PN; Bateman NW; Darcy KM; Hamilton CA; Maxwell GL; Bakkenist CJ; Conrads TP
Gynecol Oncol; 2015 Mar; 136(3):554-61. PubMed ID: 25560806
[TBL] [Abstract][Full Text] [Related]
14. A novel interplay between the Fanconi anemia core complex and ATR-ATRIP kinase during DNA cross-link repair.
Tomida J; Itaya A; Shigechi T; Unno J; Uchida E; Ikura M; Masuda Y; Matsuda S; Adachi J; Kobayashi M; Meetei AR; Maehara Y; Yamamoto K; Kamiya K; Matsuura A; Matsuda T; Ikura T; Ishiai M; Takata M
Nucleic Acids Res; 2013 Aug; 41(14):6930-41. PubMed ID: 23723247
[TBL] [Abstract][Full Text] [Related]
15. Convergence of the fanconi anemia and ataxia telangiectasia signaling pathways.
Taniguchi T; Garcia-Higuera I; Xu B; Andreassen PR; Gregory RC; Kim ST; Lane WS; Kastan MB; D'Andrea AD
Cell; 2002 May; 109(4):459-72. PubMed ID: 12086603
[TBL] [Abstract][Full Text] [Related]
16. Suppression of Tousled-like kinase activity after DNA damage or replication block requires ATM, NBS1 and Chk1.
Krause DR; Jonnalagadda JC; Gatei MH; Sillje HH; Zhou BB; Nigg EA; Khanna K
Oncogene; 2003 Sep; 22(38):5927-37. PubMed ID: 12955071
[TBL] [Abstract][Full Text] [Related]
17. Carcinogen-induced S-phase arrest is Chk1 mediated and caffeine sensitive.
Guo N; Faller DV; Vaziri C
Cell Growth Differ; 2002 Feb; 13(2):77-86. PubMed ID: 11864911
[TBL] [Abstract][Full Text] [Related]
18. ATR signaling cooperates with ATM in the mechanism of low dose hypersensitivity induced by carbon ion beam.
Xue L; Furusawa Y; Yu D
DNA Repair (Amst); 2015 Oct; 34():1-8. PubMed ID: 26246317
[TBL] [Abstract][Full Text] [Related]
19. Molecular Pathways: Targeting ATR in Cancer Therapy.
Karnitz LM; Zou L
Clin Cancer Res; 2015 Nov; 21(21):4780-5. PubMed ID: 26362996
[TBL] [Abstract][Full Text] [Related]
20. Proteasome function is required for DNA damage response and fanconi anemia pathway activation.
Jacquemont C; Taniguchi T
Cancer Res; 2007 Aug; 67(15):7395-405. PubMed ID: 17671210
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
